U.S. markets open in 8 hours 42 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.23+0.31 (+1.48%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/16/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.72
52-Week Change 346.82%
S&P500 52-Week Change 341.30%
52 Week High 331.18
52 Week Low 312.20
50-Day Moving Average 322.74
200-Day Moving Average 324.43

Share Statistics

Avg Vol (3 month) 3566.79k
Avg Vol (10 day) 3946.23k
Shares Outstanding 5116.63M
Implied Shares Outstanding 6N/A
Float 97.09M
% Held by Insiders 19.71%
% Held by Institutions 172.40%
Shares Short (Apr 29, 2021) 410.05M
Short Ratio (Apr 29, 2021) 422.12
Short % of Float (Apr 29, 2021) 412.94%
Short % of Shares Outstanding (Apr 29, 2021) 48.62%
Shares Short (prior month Mar 30, 2021) 410.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 29.23%
Operating Margin (ttm)32.38%

Management Effectiveness

Return on Assets (ttm)13.80%
Return on Equity (ttm)21.60%

Income Statement

Revenue (ttm)340.06M
Revenue Per Share (ttm)2.93
Quarterly Revenue Growth (yoy)-14.80%
Gross Profit (ttm)348.29M
EBITDA 110.67M
Net Income Avi to Common (ttm)99.41M
Diluted EPS (ttm)0.78
Quarterly Earnings Growth (yoy)-22.00%

Balance Sheet

Total Cash (mrq)372.96M
Total Cash Per Share (mrq)3.2
Total Debt (mrq)2.07M
Total Debt/Equity (mrq)0.41
Current Ratio (mrq)10.09
Book Value Per Share (mrq)4.39

Cash Flow Statement

Operating Cash Flow (ttm)144.12M
Levered Free Cash Flow (ttm)112.43M